Ignite Creation Date:
2024-05-06 @ 6:08 PM
Last Modification Date:
2024-10-26 @ 2:42 PM
Study NCT ID:
NCT05563844
Status:
RECRUITING
Last Update Posted:
2024-01-19
First Post:
2022-09-28
Brief Title:
Study of Purinostat Mesylate for Injection in the Treatment of Diffuse Large B-cell Lymphoma DLBCL
Sponsor:
Chengdu Zenitar Biomedical Technology Co Ltd
Organization:
Chengdu Zenitar Biomedical Technology Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-28
First Submit QC Date:
September 28 2022
Study First Post Date:
2022-10-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-17
Last Update Post Date:
2024-01-19
Last Update Post Date Type:
ACTUAL